
Umamaheswari Ramachandran
Examiner (ID: 19568, Phone: (571)272-9926 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617 |
| Total Applications | 1600 |
| Issued Applications | 704 |
| Pending Applications | 154 |
| Abandoned Applications | 762 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17799011
[patent_doc_number] => 11413277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Non-aqueous liquid nimodipine compositions
[patent_app_type] => utility
[patent_app_number] => 17/558924
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10299
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558924 | Non-aqueous liquid nimodipine compositions | Dec 21, 2021 | Issued |
Array
(
[id] => 17532316
[patent_doc_number] => 20220110925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Non-Aqueous Liquid Nimodipine Compositions
[patent_app_type] => utility
[patent_app_number] => 17/558919
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558919 | Non-Aqueous Liquid Nimodipine Compositions | Dec 21, 2021 | Abandoned |
Array
(
[id] => 17655262
[patent_doc_number] => 20220175727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions
[patent_app_type] => utility
[patent_app_number] => 17/554842
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554842 | Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions | Dec 16, 2021 | Issued |
Array
(
[id] => 17655310
[patent_doc_number] => 20220175775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/549828
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549828
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549828 | N-substituted indole derivatives as PGE2 receptor modulators | Dec 12, 2021 | Issued |
Array
(
[id] => 17685780
[patent_doc_number] => 20220193072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADER
[patent_app_type] => utility
[patent_app_number] => 17/548842
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548842 | METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADER | Dec 12, 2021 | Pending |
Array
(
[id] => 17593568
[patent_doc_number] => 20220143141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/643751
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17643751
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/643751 | COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE | Dec 9, 2021 | Abandoned |
Array
(
[id] => 18876710
[patent_doc_number] => 20240000079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => LIQUID PESTICIDAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/254828
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254828
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254828 | LIQUID PESTICIDAL COMPOSITION | Nov 29, 2021 | Pending |
Array
(
[id] => 17458670
[patent_doc_number] => 20220071974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => Non-Aqueous Liquid Nimodipine Compositions
[patent_app_type] => utility
[patent_app_number] => 17/530728
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/530728 | Non-aqueous liquid nimodipine compositions | Nov 18, 2021 | Issued |
Array
(
[id] => 18737870
[patent_doc_number] => 20230346770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => COMBINATION OF BEDAQUILINE, ETHAMBUTOL AND A MACROLIDE IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/199748
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199748
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/199748 | COMBINATION OF BEDAQUILINE, ETHAMBUTOL AND A MACROLIDE IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIAL DISEASES | Nov 9, 2021 | Abandoned |
Array
(
[id] => 19290394
[patent_doc_number] => 12029733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system
[patent_app_type] => utility
[patent_app_number] => 17/506354
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 27
[patent_no_of_words] => 31594
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506354 | Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system | Oct 19, 2021 | Issued |
Array
(
[id] => 18646987
[patent_doc_number] => 20230292754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Pest Repellents and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/771622
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771622 | Pest Repellents and Uses Thereof | Oct 17, 2021 | Abandoned |
Array
(
[id] => 18784720
[patent_doc_number] => 20230372330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => COMPOUNDS FOR TREATMENT OF HEMOLYSIS-AND INFLAMMASOME-ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/248644
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248644
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248644 | Compounds for treatment of hemolysis-and inflammasome-associated diseases | Oct 12, 2021 | Issued |
Array
(
[id] => 19423726
[patent_doc_number] => 12083117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Compositions and kits useful for treatment of respiratory illness
[patent_app_type] => utility
[patent_app_number] => 17/498152
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4943
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498152 | Compositions and kits useful for treatment of respiratory illness | Oct 10, 2021 | Issued |
Array
(
[id] => 17576822
[patent_doc_number] => 20220133677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => TOPICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/498147
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498147
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498147 | Topical composition | Oct 10, 2021 | Issued |
Array
(
[id] => 17974288
[patent_doc_number] => 11491125
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-08
[patent_title] => Baclofen formulations and methods of minimizing patient exposure to metabolite variations
[patent_app_type] => utility
[patent_app_number] => 17/489343
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18226
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489343 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Sep 28, 2021 | Issued |
Array
(
[id] => 18690844
[patent_doc_number] => 20230321002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => ANTICOCCIDIAL COMPOSITION COMPRISING STILBENE-BASED COMPOUND, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/024948
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024948
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024948 | Anticoccidial composition comprising stilbene-based compound, and use thereof | Sep 23, 2021 | Issued |
Array
(
[id] => 18724203
[patent_doc_number] => 20230338328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => KOJIC ACID DERIVATIVE AS SELECTIVE INHIBITOR OF MITOSIS IN COLORECTAL AND GLIOBLASTOMA CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 18/026980
[patent_app_country] => US
[patent_app_date] => 2021-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026980 | KOJIC ACID DERIVATIVE AS SELECTIVE INHIBITOR OF MITOSIS IN COLORECTAL AND GLIOBLASTOMA CANCER CELLS | Sep 17, 2021 | Pending |
Array
(
[id] => 17471650
[patent_doc_number] => 20220079154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => AGRICULTURAL FORMULATIONS, USES THEREOF AND PROCESSES FOR PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/472864
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472864 | Agricultural formulations, uses thereof and processes for preparation thereof | Sep 12, 2021 | Issued |
Array
(
[id] => 19792119
[patent_doc_number] => 12233042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Treatment of cutaneous disorders
[patent_app_type] => utility
[patent_app_number] => 17/471853
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21522
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471853 | Treatment of cutaneous disorders | Sep 9, 2021 | Issued |
Array
(
[id] => 18953486
[patent_doc_number] => 20240041813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID HYDROXYLATED DERIVATIVES, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/025604
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025604 | VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID HYDROXYLATED DERIVATIVES, AND METHODS OF USE | Sep 9, 2021 | Pending |